All News

Men taking statin drugs had a modest reduction in prostate growth in a new analysis of a 4-year, large, randomized trial of the dual 5-alpha-reductase inhibitor dutasteride (Avodart) versus placebo for risk reduction of prostate cancer among high-risk men.

Photoselective vaporization of the prostate using the GreenLight XPS 180W laser system (American Medical Systems, Minnetonka, MN) is associated with reduced operative time and fiber usage compared with the GreenLight HPS 120W while resulting in lower PSA levels 6 months post-procedure.

Men with low-risk prostate cancer have good mortality prospects even when they experience early biochemical recurrence following radical prostatectomy, according to the results of an Australian study.

The autonomy of a growing number of employed physicians should be respected, and patient care should come before the financial interests of employers, according to principles on physician employment adopted at the recent American Medical Association interim meeting in Honolulu.

Men who had high levels of the activated Stat5 protein in their prostate cancer after a radical prostatectomy were more likely to have a recurrence or die from the disease compared to men who had little to no presence of the growth protein, according to a recent report.

For nearly half of U.S. urologists, malpractice insurance premiums in 2011 stayed the same as 2010 levels, according to a recent survey.

Stenting a pelvic artery may be a treatment option for erectile dysfunction (ED) in men who don't respond to drug therapy, according to a recent study.

Aerobic exercise can help relieve fatigue associated with prostate and breast cancer and treatment for those diseases, say British researchers.

Merck has confirmed that the FDA Nonprescription Drug Advisory Committee proposed that the FDA consider labeling modifications as part of its review of oxybutynin transdermal system (Oxytrol) as an over-the-counter treatment for overactive bladder in women.

More than two-thirds of U.S. primary care physicians now use electronic health records (EHRs), but less than one-fifth report that they routinely receive timely information from specialists or hospitals, according to a survey of physicians in the U.S. and nine other countries.

The FDA recently granted clearance to separate devices for bladder scanning and placement of suprapubic catheters.

An experimental form of brachytherapy was highly efficacious and minimally toxic to healthy tissue in a mouse model of cancer, according to a recent study.

Recent research suggests that two components of red meat?dietary protein and dietary iron?may combine to form powerful carcinogens that increase risk for bladder cancer.

Low depressive symptoms and a longer telomere length are compelling factors that contribute to a prolonged life for bladder cancer patients, say researchers at The University of Texas MD Anderson Cancer Center, Houston.

Women without pregnancy complications or maternal risk factors for complications have low rates of significant pelvic floor dysfunction after giving birth, whether they deliver vaginally or via cesarean section, recent research shows.

An implantable tibial nerve stimulation device appears to be safe and durable in patients with overactive bladder, results of a long-term pilot study showed.

Preoperative urodynamic testing in women undergoing surgery for uncomplicated, stress-predominant urinary incontinence commonly results in a change in clinical diagnosis.

Mishaps around the home that lead to emergency room visits for genital injuries are common and may be preventable, according to a comprehensive survey of genital injuries over the last decade conducted by urologists at the University of California, San Francisco.

A recently published study supports the adoption of a new biomarker to measure the aggressiveness of primary prostate tumors.

Stereotactic body radiotherapy appears to be an effective treatment option for patients with organ-confined prostate cancer, according to two separate studies presented at the American Association for Radiation Oncology annual meeting in Boston.

An online poll of New England Journal of Medicine readers shows a lack of consensus over prostate cancer screening, with a little over half of respondents recommending screening for a 55-year-old man.

Urologists who treat Medicare patients face a 1% pay cut under a Centers for Medicare & Medicaid Services final rule with comment period issued Nov. 1.

Less than 5% of websites describing prostate cancer are written below a high school reading level, even though 90 million American adults read below this level, a new study found.

A new online medical database designed to help men diagnosed with low-grade prostate cancer track the progression of their disease while avoiding complications from overtreatment recently launched.

Stereotactic radiosurgery shows promise as a therapeutic option for patients with localized primary renal cancer who are considered poor surgical candidates and who do not have a prior history of pelvic or abdominal radiation, according to research presented at the American Society for Radiation Oncology annual meeting in Boston.

Annual PSA screening yields a greater quality-adjusted life expectancy among patients who have a high risk of developing metastatic disease in comparison to unscreened patients, according to a recent study.

A recent report from the Government Accountability Office (GAO) is highly critical of physician self-referral for advanced imaging services, indicating that it significantly raises Medicare costs.